Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-25-007626
Filing Date
2025-02-19
Accepted
2025-02-19 21:27:39
Documents
1
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 5  
1 ownership.xml 5 3262
  Complete submission text file 0001493152-25-007626.txt   4891
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Issuer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 449 S. 12TH STREET UNIT 1705 TAMPA FL 33602
Business Address
Yanez Michelle (Reporting) CIK: 0001958023 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-13467 | Film No.: 25642987